Nuvation Bio
NUVB
NUVB
148 hedge funds and large institutions have $447M invested in Nuvation Bio in 2024 Q2 according to their latest regulatory filings, with 42 funds opening new positions, 46 increasing their positions, 39 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
148
Holders Change
+24
Holders Change %
+19.35%
% of All Funds
2.15%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
42
Increased
46
Reduced
39
Closed
17
Calls
$30K
Puts
$20K
Net Calls
+$10K
Net Calls Change
-$205K
Top Buyers
| 1 |
DC
Decheng Capital
Menlo Park,
California
|
$20.3M |
| 2 |
BlackRock
New York
|
$47.4M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
$29.6M |
| 4 |
LCM
Laurion Capital Management
New York
|
$4.65M |
| 5 |
GTC
Ghost Tree Capital
New York
|
$3.36M |
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
$644K |
| 2 |
OCA
Octagon Capital Advisors
New York
|
$1.26M |
| 3 |
OFM
Omega Fund Management
Boston,
Massachusetts
|
$38.8M |
| 4 |
D.E. Shaw & Co
New York
|
$502K |
| 5 |
SCM
Sio Capital Management
New York
|
$1.95M |
